Alector, Inc.

NASDAQ:ALEC

Biotechnology

Healthcare
$2.57 +5.13%

+$0.08 today

Market cap
$382.61M
Beta
0.59
P/E (TTM)
-1.4
EPS (TTM)
-$1.13
52W Low $1.09High $3.40

Volume 2.13M

Average 0.65M

ALEC Other Current Assets

Current assets not reported separately, such as prepaid expenses.

Alector, Inc.NASDAQ: ALEC

Other Current Assets · Q1 FY2026 · quarter ended Mar 2026

Other current assets falls 29.2% from a year ago

Other current assets stood at $8.57M at the end of Q1 FY2026, down 29.2% from a year earlier and down 17.8% from the prior quarter.

Context

  • Other current assets amounted to 3.6% of total assets at the end of Q1 FY2026, up 0.6 pp from a year earlier.
  • Other current assets increased in 1 of the last 3 fiscal years.

What to watch

Whether other current assets keeps falling in the next quarterly balance sheet after a -29.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$8.57M-17.8% QoQ
Last fiscal yearDec 2025
$10.43M-8.7% YoY
Year agoMar 2025
$12.1M-29.2% since
Other Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-29.2%——
1 year-8.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Current Assets history

USD · from the balance sheet

Latest · FY2025
10.43M USD
Year-over-year change
-8.7%

Other Current Assets vs competitors

How ALEC compares with its peers on the latest reported figures

  • Peers report in different currencies, so other current assets is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -29.2% is the 7th highest of 9, against a peer median of -18.4%.
  • Other current assets amounts to 3.6% of total assets for ALEC, versus a peer median of 1.4%.
ALEC Competitors
Other Current Assets for ALEC and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALECAlector, Inc.Mar 2026$8.57M USD-29.2%—3.6%
FATEFate Therapeutics, Inc.Mar 2026$4M USD-25.7%-46.8%1.4%
IRDOpus Genetics, Inc.Mar 2026$3.93M USD+184.6%+181.7%5.9%
NKTXNkarta, Inc.Mar 2026$3.76M USD+3.1%-36.7%1.0%
ABOSAcumen Pharmaceuticals, Inc.Mar 2026$3.57M USD-27.7%+43.1%2.7%
VORVor Biopharma Inc.Mar 2026$2.86M USD+862.6%-9.3%0.6%
CRBPCorbus Pharmaceuticals Holdings, Inc.Mar 2026$2.08M USD-54.4%+98.9%1.4%
PEPGPepGen Inc.Mar 2026$1.97M USD-39.7%-16.3%1.3%
MOLNMolecular Partners AGMar 2026CHF 1.84M CHF-11.0%—2.1%
Peer median (excluding ALEC) —-18.4%-9.3%1.4%

Competitors are the stored peer set for ALEC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents329.15M154.32M74.56M33.02M65.8M
Short-term Investments406.1M558.53M474.31M380.38M190.22M
Net Receivables7.39M2.59M000
Inventory00000
Other Current Assets0016.95M11.42M10.43M
Total Current Assets749.71M726.44M565.81M424.82M266.45M
Property, Plant & Equipment (Net)57.9M53.33M47.06M37.1M24.55M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets7.05M7.88M8.96M6.39M2.23M
Total Non-current Assets64.95M61.21M56.02M43.49M26.79M
Total Assets814.66M787.65M621.83M468.3M293.24M
Account Payables4.75M4.19M3.78M2.22M1.69M
Short-term Debt0000366K
Tax Payables00000
Deferred Revenue90.8M48.23M82.98M23.66M6.68M
Other Current Liabilities11.66M12.76M54.74M54.55M24.39M
Total Current Liabilities139.56M93.81M177.95M125.06M69.5M
Long-term Debt0009.39M9.32M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)334.42M443.37M210.85M172.17M164.54M
Other Non-current Liabilities158K759K68.42M10.51M1.74M
Total Non-current Liabilities374.38M479.4M309.72M216.44M193.09M
Total Liabilities513.93M573.21M487.67M341.5M262.59M
Common Stock8K8K8K9K11K
Retained Earnings(446.38M)(579.69M)(710.08M)(829.13M)(972.06M)
Accumulated OCI(943K)(4.58M)184K261K166K
Other Stockholders Equity00000
Minority Interest00000
Total Equity300.72M214.44M134.16M126.8M30.65M
Total Debt47.6M43.33M38.92M42.52M36.23M
Net Debt(281.55M)(111M)(35.64M)9.5M(29.57M)

Alector, Inc.

NASDAQ:ALEC

Intrinsic Alpha fair value

Locked

Current Price

$2.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.